Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Pancreatic exocrine insufficiency after bariatric surgery

Title: Pancreatic exocrine insufficiency after bariatric surgery
Authors: Vujasinovic, Miroslav; Valente, Roberto; Thorell, Anders; Rutkowski, Wiktor; Haas, Stephan L.; Arnelo, Urban; Martin, Lena; Löhr, J. -Matthias
Contributors: Vujasinovic, Miroslav; Valente, Roberto; Thorell, Ander; Rutkowski, Wiktor; Haas, Stephan L.; Arnelo, Urban; Martin, Lena; Löhr, J. -Matthias
Publisher Information: MDPI AG; Postfach
Publication Year: 2017
Collection: Sapienza Università di Roma: CINECA IRIS
Subject Terms: bariatric surgery; exocrine; insufficiency; obesity; pancrea; biomarker; enzyme replacement therapy; exocrine pancreatic insufficiency; fece; human; morbid; pancreatic elastase; predictive value of test; risk factor; treatment outcome; food science; nutrition and dietetics
Description: Morbid obesity is a lifelong disease, and all patients require complementary follow-up including nutritional surveillance by a multidisciplinary team after bariatric procedures. Pancreatic exocrine insufficiency (PEI) refers to an insufficient secretion of pancreatic enzymes and/or sodium bicarbonate. PEI is a known multifactorial complication after upper gastrointestinal surgery, and might constitute an important clinical problem due to the large number of bariatric surgical procedures in the world. Symptoms of PEI often overlap with sequelae of gastric bypass, making the diagnosis difficult. Steatorrhea, weight loss, maldigestion and malabsorption are pathognomonic for both clinical conditions. Altered anatomy after bypass surgery can make the diagnostic process even more difficult. Fecal elastase-1 (FE1) is a useful diagnostic test. PEI should be considered in all patients after bariatric surgery with prolonged gastrointestinal complaints that are suggestive of maldigestion and/or malabsorption. Appropriate pancreatic enzyme replacement therapy should be part of the treatment algorithm in patients with confirmed PEI or symptoms suggestive of this complication.
Document Type: article in journal/newspaper
Language: English
Relation: info:eu-repo/semantics/altIdentifier/pmid/29137169; info:eu-repo/semantics/altIdentifier/wos/WOS:000416547200079; volume:9; issue:11; firstpage:1; lastpage:8; numberofpages:8; journal:NUTRIENTS; http://hdl.handle.net/11573/1187168
DOI: 10.3390/nu9111241
Availability: http://hdl.handle.net/11573/1187168; https://doi.org/10.3390/nu9111241
Rights: info:eu-repo/semantics/openAccess
Accession Number: edsbas.FD34267E
Database: BASE